BOLA2B and neuroblastoma: As shown in Figure 2B, high expression of BOLA2B predicted better OS in OV patients, while in other cancers, such as NB, GBM, UVM, KIRC, LIHC, KIPAN, LGG, and ACC, patients with low BOLA2B expression showed better OS rates.